Navigation Links
The Healthcare Supply Chain to Connect in Chicago for the 2008 GHX Supply Chain Summit
Date:3/25/2008

More than 500 hospital and supplier representatives expected to attend

healthcare's largest forum focused on all supply chain participants

LOUISVILLE, Colo., March 25 /PRNewswire/ -- More than 500 hospital and supplier representatives will gather in Chicago, April 16-18 for the 2008 GHX Supply Chain Summit to share best practices and identify opportunities for greater collaboration to improve operational performance. The GHX Supply Chain Summit is the largest healthcare forum in the U.S. focused on both the buy and sell side of the supply chain. GHX currently facilitates transactions between more than 6000 providers and 600 suppliers in North America. Participation in GHX is not a prerequisite to attend the event.

Highlights of this year's event include presentations and panel discussions on enhancing the role the supply chain plays in supporting clinical functions and increasing patient safety. The Summit will close with an inside look at this fall's presidential election, including the impact on healthcare, with former presidential candidate Pat Buchanan and former Democratic National Committee Chairman Terry McAuliffe, who also serves as chairman of the Hillary Clinton for President campaign.
Other agenda highlights include:

For Providers:

-- Utilizing artificial intelligence to create a content management

strategy that can be customized to meet the needs of your entire

organization

-- What innovative hospitals are doing in the area of AP automation,

presented by Paystream Advisors

-- Linking supply chain, clinical and financial data to address higher

physician preference item costs, declining reimbursements and demands

for price and quality transparency

For Suppliers

-- Building a best-in-class framework for business intelligence, presented

by The Aberdeen Group

-- Using technology to better manage and track consignment inventor
'/>"/>

SOURCE GHX
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. High-Performing Healthcare Organizations Have Seven Qualities in Common
2. Methodist Healthcare - Memphis Hospitals Announces the Extension of Tender Offers
3. MarketResearch.com Announces Distribution of Wireless Healthcare Research
4. Three Out of Four Pennsylvania Voters Support Increased State Funding for Home Healthcare Services
5. DNV Healthcare Advances in Bid to Accredit Hospitals
6. AUDIO from Medialink and UnitedHealthcare: Medicare Open Enrollment Ends March 31
7. RxElite Awarded Anesthetic Gases Multi-Source Contract by Premier Inc., a Purchasing Network for More than 1,500 U.S. Hospitals and 49,000 Other Healthcare Sites
8. MEDai Assists Healthcare Organizations Demonstrate the Value of Predictive Modeling
9. Arthur J. Gallagher & Co. Acquires Healthcare Risk Solutions, LLC
10. Mirixas Healthcare Success in Software-as-a-Service and IT/Business Integration Recognized in Gartner Publication
11. eMPR Digital Drug Reference Reaches 50,000 Downloads and the Publisher Launches a Raffle for Healthcare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2008)... Biggs Named Spokesperson for Education Campaign o...lpha-1 Proteinase Inhibitor (Human) Augmentation ...USSIA, Pa., May 17 /PRNewswire/ -- Melissa Biggs, ...watch was recently named,spokesperson for an educa...ing Americans to get tested for alpha-1 antitrypsi...
(Date:5/16/2008)... BENSALEM, Pa., May 16 /PRNewswire/ -- Law Offi...eadline to move to be a lead plaintiff in the,secu... persons who,purchased or otherwise acquired the c... ("Inverness Medical" or the "Company") (Amex: IM...or about November 14, 2007 (the,"Class Period"). T...
(Date:5/16/2008)...Consumers could report side effects, but critics w...IDAY, May 16 (HealthDay News) -- Direct-to-consume...e phone number that would allow consumers to repor...ted Friday. , The experts serve on a panel that...ch phone numbers are already mandated by the FDA f...
(Date:5/16/2008)... Contract Covers More than 500 Workers, WASHIN...500 paramedics,and emergency medical technicians i...ington area have ratified their first-ever contrac...these workers are now covered by a,strong contract...ement,future," said Teamsters General President Ji...
Breaking Medicine News(10 mins):Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 2Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 3Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 4Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 5Health News:Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc. 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 3
...na is perhaps one of the worst AIDS affected count...The Government has promised free treatment to all ...of AIDS infected people in the country amounts to ...anti-retroviral medicines which serve to prolong l...
...aric oxygen treatments boost tissue repair and rec...of circulating stem cells, according to a new stud...06 issue of American Journal of Physiology-Heart a...l course of hyperbaric oxygen treatments increases...
...is likely to be using sub-standard poultry vaccine...ly H5N1 bird flu virus in poultry, experts feel //... mutate from a disease that largely affects birds ...ween people, leading to a human pandemic. Since l...
...nse pill to keep soldiers alert in the field by pr...drinkers is being developed by defense scientists ...rst extensive study of the effects of caffeine on ...ngapore's leading defence research organization, ...
Other Medicine News:Health News:Botswana Continues Its Fight Against AIDS 2Health News:Bad vaccines may trigger China bird flu 2
(Date:5/15/2008)...ted amount of research reflects depth and breadth ... develop new treatments for ...ghlight impact of Zometa(R), the leading IV, bisph...stage breast cancer, - Four oral sessions to feat...bitor of mTOR, including first results of RECORD-1...
(Date:5/15/2008)....J., May 15 /- Sanofi-avent...hat findings from the,landmark ATHENA study showed...the treatment of patients with atrial fibrillation...scular hospitalizations or death from any,cause by...eeting the study,primary endpoint. The ATHENA resu...
(Date:5/15/2008)...tzerland, May 15 /- Ergonex Pharma to... Administration (FDA) has,granted orphan drug desi...y,arterial hypertension (PAH). Terguride is curren...trial in Europe., "The FDA,s grant of orphan drug...trengthens our development program by offering reg...
(Date:5/15/2008)..., May 15 /- Novavax, Inc. (...d enrollment in the Phase I/IIa,study of its pande...mately,230 subjects. Favorable interim results fro...e-escalation in 70 healthy adult volunteers, were,...ggested that the vaccine,is well tolerated and imm...
Breaking Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 3Providence Saint Joseph Medical Named LA Countys Third Primary Stroke Center 16369 1Providence Saint Joseph Medical Named LA Countys Third Primary Stroke Center 16369 2Nickelodeon Gives Kids a Platform to Voice Their Opinions on Nick News with Linda Ellerbee 3A Election Issues 08 Premiering Sunday April 13 at 9 3A0 16364 1Nickelodeon Gives Kids a Platform to Voice Their Opinions on Nick News with Linda Ellerbee 3A Election Issues 08 Premiering Sunday April 13 at 9 3A0 16364 2Nickelodeon Gives Kids a Platform to Voice Their Opinions on Nick News with Linda Ellerbee 3A Election Issues 08 Premiering Sunday April 13 at 9 3A0 16364 3Nickelodeon Gives Kids a Platform to Voice Their Opinions on Nick News with Linda Ellerbee 3A Election Issues 08 Premiering Sunday April 13 at 9 3A0 16364 4New research shows neuroprotective effect of lovastatin 16362 1Power of molecular imaging reveals secrets of the heart 2830 1Power of molecular imaging reveals secrets of the heart 2830 2
...sh Columbia, March 12, 2007--Inflazyme,Pharmaceuti...2007,the preliminary results of the Phase 2b CAPS... clinical difference between,patients who received...s surprisingly large and consistent across a numbe... by Inflazyme and its,external experts to determin...
...tes second quarter BLA filing for C1-inhibitor,rep...wire-FirstCall/ -- Lev,Pharmaceuticals, Inc. (Lev)... U.S. Phase III trial of C1-esterase inhibitor (C1...dema (HAE). In the,acute study, which is part of t...tary Angioedema Nanofiltration Generation,evaluati...
Other Medicine Technology:Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 2Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 2Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 5
The EK-H Series offer 10 selectable units of measure
Digital Thermometer & High-Low Temp Alarm, -50C to +90C
Thermometer for Round Water Bath
... Independent controls for Digital Thermostat and D...el front. Anodized aluminum ends. , Interiorwhite... floor. , Oversized refrigeration (134A). , Temp...ing doors. , Foamed-in-place polyurethane high de...
Medicine Products: